why choose us

First received: November 13, 2023

Clinical Trial: A Study to See How Safe and Tolerable Different Doses of REGN13335 Are When Administered Intravenously (IV) or Subcutaneously (SC) to Healthy Adult Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Volunteers

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenously or Subcutaneously Administered REGN13335, a Platel

Brief Summary: This study is researching an experimental drug called REGN13335.This is the first time that REGN13335 will be given to people.This study will enroll healthy adults.The aim of the study is to see how safe and tolerable REGN13335 is in healthy volunteers.The study is looking at several other research questions, including:What side effects may happen from taking the study drugHow much study drug is present in the blood of study participants at different timesWhether the body makes antibodies against the study drug…

Read more